Filtros : "MIOSITE" "Miossi, R." Limpar

Filtros



Refine with date range


  • Source: Reumatismo. Unidade: FM

    Subjects: DOENÇAS MUSCULARES, ATROFIA MUSCULAR, MIOSITE, CURVATURAS DA COLUNA VERTEBRAL

    Acesso à fonteAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      ARAUJO, C. S. R. et al. Brachio-cervical inflammatory myopathy associated with systemic sclerosis. Case series and review of literature. Reumatismo, v. 73, n. 2, p. 122-130, 2021Tradução . . Disponível em: https://doi.org/10.4081/reumatismo.2021.1397. Acesso em: 22 ago. 2024.
    • APA

      Araujo, C. S. R., Miossi, R., Souza, F. H. C. de, Costa, M. D., Silva, A. M. S. da, Campos, E. D., et al. (2021). Brachio-cervical inflammatory myopathy associated with systemic sclerosis. Case series and review of literature. Reumatismo, 73( 2), 122-130. doi:10.4081/reumatismo.2021.1397
    • NLM

      Araujo CSR, Miossi R, Souza FHC de, Costa MD, Silva AMS da, Campos ED, Zanoteli E, Shinjo SK. Brachio-cervical inflammatory myopathy associated with systemic sclerosis. Case series and review of literature [Internet]. Reumatismo. 2021 ; 73( 2): 122-130.[citado 2024 ago. 22 ] Available from: https://doi.org/10.4081/reumatismo.2021.1397
    • Vancouver

      Araujo CSR, Miossi R, Souza FHC de, Costa MD, Silva AMS da, Campos ED, Zanoteli E, Shinjo SK. Brachio-cervical inflammatory myopathy associated with systemic sclerosis. Case series and review of literature [Internet]. Reumatismo. 2021 ; 73( 2): 122-130.[citado 2024 ago. 22 ] Available from: https://doi.org/10.4081/reumatismo.2021.1397
  • Source: Clinical and experimental rheumatology. Unidade: FM

    Subjects: MIOSITE, FÁRMACOS IMUNOSSUPRESSORES, EVENTO ADVERSO A MEDICAMENTO

    Acesso à fonteHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      SOUZA, R. C. de et al. Efficacy and safety of leflunomide as an adjuvant drug in refractory dermatomyositis with primarily cutaneous activity. Clinical and experimental rheumatology, v. 35, n. 6, p. 1011-1013, 2017Tradução . . Disponível em: http://observatorio.fm.usp.br/handle/OPI/25488. Acesso em: 22 ago. 2024.
    • APA

      Souza, R. C. de, Souza, F. H. C. de, Miossi, R., & Shinjo, S. M. O. (2017). Efficacy and safety of leflunomide as an adjuvant drug in refractory dermatomyositis with primarily cutaneous activity. Clinical and experimental rheumatology, 35( 6), 1011-1013. Recuperado de http://observatorio.fm.usp.br/handle/OPI/25488
    • NLM

      Souza RC de, Souza FHC de, Miossi R, Shinjo SMO. Efficacy and safety of leflunomide as an adjuvant drug in refractory dermatomyositis with primarily cutaneous activity [Internet]. Clinical and experimental rheumatology. 2017 ; 35( 6): 1011-1013.[citado 2024 ago. 22 ] Available from: http://observatorio.fm.usp.br/handle/OPI/25488
    • Vancouver

      Souza RC de, Souza FHC de, Miossi R, Shinjo SMO. Efficacy and safety of leflunomide as an adjuvant drug in refractory dermatomyositis with primarily cutaneous activity [Internet]. Clinical and experimental rheumatology. 2017 ; 35( 6): 1011-1013.[citado 2024 ago. 22 ] Available from: http://observatorio.fm.usp.br/handle/OPI/25488

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2024